GABA Pharmacology: The Search for Analgesics

Neurochemical Research

Volumn 39, Issue 10, 2014, Pages 1948-1963

  McCarson, Kenneth E ^a   Enna, S J ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

GABA pharmacology; GABAA receptors; GABAB receptors; Neuropathic pain; Nociception

Indexed keywords

3 AMINOPROPYL(METHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ARECAIDINE; BACLOFEN; BICUCULLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; GABAPENTIN; GLUTAMIC ACID; IMIPRAMINE; MUSCIMOL; NS 11394; PHACLOFEN; SUBSTANCE P; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR;

4 AMINOBUTYRIC ACID METABOLISM; 4 AMINOBUTYRIC ACID UPTAKE; ALLODYNIA; ANTINOCICEPTION; BRAIN; CONFORMATIONAL TRANSITION; GABAERGIC TRANSMISSION; HUMAN; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PLASTICITY; PROTEIN LOCALIZATION; REVIEW; SPINAL CORD; STOICHIOMETRY; DRUG EFFECTS; METABOLISM; PAIN;

ANALGESICS; GAMMA-AMINOBUTYRIC ACID; HUMANS; PAIN; RECEPTORS, GABA;

EID: 84918772411     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-014-1254-x     Document Type: Review

References (150)

1. Bowery NG, Enna SJ (2000) Gamma-aminobutyric acid(B) receptors: first of the functional metabotropic heterodimers. J Pharmacol Exp Ther 292:2–7
2. Enna SJ, McCarson KE (2006) The role of GABA in the mediation and perception of pain. Adv Pharmacol 54:1–27
3. Mohler H (2001) Functions of GABAA-receptor: pharmacology and pathophysiology. In: Mohler H (ed) Pharmacology of GABA and glycine neurotransmission. Springer, Berlin, pp 101–116
4. Kendall DA, Browner M, Enna SJ (1982) Comparison of the antinociceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement. J Pharmacol Exp Ther 220:482–487
5. Levy RA, Proudfit HK (1977) The analgesic action of baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid]. J Pharmacol Exp Ther 202:437–445
6. Malan TP, Mata HP, Porreca F (2002) Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain. Anesthesiology 96:1161–1167
7. Shafizadeh M, Semnanian S, Zarrindast MR, Hashemi B (1997) Involvement of GABAB receptors in the antinociception induced by baclofen in the formalin test. Gen Pharmacol 28:611–615
8. Smith GD, Harrison SM, Birch PJ, Elliott PJ, Malcangio M, Bowery NG (1994) Increased sensitivity to the antinociceptive activity of (±)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia. Neuropharmacology 33:1103–1108
9. Enna SJ, Harstad EB, McCarson KE (1998) Regulation of neurokinin-1 receptor expression by GABA(B) receptor agonists. Life Sci 62:1525–1530
10. Malcangio M, Libri V, Teoh H, Constanti A, Bowery NG (1995) Chronic (-)baclofen or CGP 36742 alters GABAB receptor sensitivity in rat brain and spinal cord. Neuroreport 6:399–403
11. Mohler HBJ, Benson B, Luscher B, Rudolph U, Fritschy JM (1997) Diversity in structure, pharmacology, and regulation of GABAA receptors. In: Enna SJ, Bowery NG (eds) The GABA receptors. Humana Press, Totowa, pp 11–36
12. Mohler H, Fritschy JM, Crestani F, Hensch T, Rudolph U (2004) Specific GABA(A) circuits in brain development and therapy. Biochem Pharmacol 68:1685–1690
13. Johnston GA, Chebib M, Hanrahan JR, Mewett KN (2010) Neurochemicals for the investigation of GABA(C) receptors. Neurochem Res 35:1970–1977
14. Hwang JH, Hwang KS, Kim JU, Choi IC, Park PH, Han SM (2001) The interaction between intrathecal neostigmine and GABA receptor agonists in rats with nerve ligation injury. Anesth Analg 93:1297–1303
15. Pelley KA, Vaught JL (1987) An antinociceptive profile of kojic amine: an analogue of gamma-aminobutyric acid (GABA). Neuropharmacology 26:301–307
16. Yuan WX, Chen SR, Chen H, Pan HL (2009) Stimulation of alpha(1)-adrenoceptors reduces glutamatergic synaptic input from primary afferents through GABA(A) receptors and T-type Ca(2 +) channels. Neuroscience 158:1616–1624
17. Gassner M, Ruscheweyh R, Sandkuhler J (2009) Direct excitation of spinal GABAergic interneurons by noradrenaline. Pain 145:204–210
18. Fenselau H, Heinke B, Sandkuhler J (2011) Heterosynaptic long-term potentiation at GABAergic synapses of spinal lamina I neurons. J Neurosci 31:17383–17391
19. Pinard A, Seddik R, Bettler B (2010) GABAB receptors: physiological functions and mechanisms of diversity. Adv Pharmacol 58:231–255
20. Gassmann M, Shaban H, Vigot R, Sansig G, Haller C, Barbieri S, Humeau Y, Schuler V, Muller M, Kinzel B, Klebs K, Schmutz M, Froestl W, Heid J, Kelly PH, Gentry C, Jaton AL, Van der Putten H, Mombereau C, Lecourtier L, Mosbacher J, Cryan JF, Fritschy JM, Luthi A, Kaupmann K, Bettler B (2004) Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J Neurosci 24:6086–6097
21. Chronwall BM, Davis TD, Severidt MW, Wolfe SE, McCarson KE, Beatty DM, Low MJ, Morris SJ, Enna SJ (2001) Constitutive expression of functional GABA(B) receptors in mIL-tsA58 cells requires both GABA(B(1)) and GABA(B(2)) genes. J Neurochem 77:1237–1247
22. Enna SJ (2001) A GABA(B) mystery: the search for pharmacologically distinct GABA(B) receptors. Mol Interventions 1:208–218
23. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE, Nagarathnam D, Noble SA, Branchek TA, Gerald C (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396:674–679
24. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A, Bettler B (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396:683–687
25. Schwenk J, Metz M, Zolles G, Turecek R, Fritzius T, Bildl W, Tarusawa E, Kulik A, Unger A, Ivankova K, Seddik R, Tiao JY, Rajalu M, Trojanova J, Rohde V, Gassmann M, Schulte U, Fakler B, Bettler B (2010) Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature 465:231–235
26. Brenowitz S, David J, Trussell L (1998) Enhancement of synaptic efficacy by presynaptic GABA(B) receptors. Neuron 20:135–141
27. Enna SJ (2001) GABAB receptor signaling pathways. In: Mohler H (ed) Pharmacology of GABA and glycine neurotransmission. Springer, Berlin, pp 329–342
28. Derjean D, Bertrand S, Le Masson G, Landry M, Morisset V, Nagy F (2003) Dynamic balance of metabotropic inputs causes dorsal horn neurons to switch functional states. Nat Neurosci 6:274–281
29. Nguyen TT, Matsumoto K, Watanabe H (1997) Involvement of supraspinal GABA-ergic systems in clonidine-induced antinociception in the tail-pinch test in mice. Life Sci 61:1097–1103
30. Thomas DA, McGowan MK, Hammond DL (1995) Microinjection of baclofen in the ventromedial medulla of rats: antinociception at low doses and hyperalgesia at high doses. J Pharmacol Exp Ther 275:274–284
31. Hurley RW, Banfor P, Hammond DL (2003) Spinal pharmacology of antinociception produced by microinjection of mu or delta opioid receptor agonists in the ventromedial medulla of the rat. Neuroscience 118:789–796
32. Thomas DA, Navarrete IM, Graham BA, McGowan MK, Hammond DL (1996) Antinociception produced by systemic R(+)-baclofen hydrochloride is attenuated by CGP 35348 administered to the spinal cord or ventromedial medulla of rats. Brain Res 718:129–137
33. Zorn SH, Enna SJ (1987) The GABA agonist THIP, attenuates antinociception in the mouse by modifying central cholinergic transmission. Neuropharmacology 26:433–437
34. Naderi N, Shafaghi B, Khodayar MJ, Zarindast MR (2005) Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat. Eur J Pharmacol 514:159–164
35. Chen SR, Pan HL (2003) Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats. Brain Res 965:67–74
36. Carlton SM, Zhou S, Coggeshall RE (1999) Peripheral GABA(A) receptors: evidence for peripheral primary afferent depolarization. Neuroscience 93:713–722
37. Desarmenien M, Feltz P, Occhipinti G, Santangelo F, Schlichter R (1984) Coexistence of GABAA and GABAB receptors on A delta and C primary afferents. Br J Pharmacol 81:327–333
38. Price GW, Wilkin GP, Turnbull MJ, Bowery NG (1984) Are baclofen-sensitive GABAB receptors present on primary afferent terminals of the spinal cord? Nature 307:71–74
39. Witschi R, Punnakkal P, Paul J, Walczak JS, Cervero F, Fritschy JM, Kuner R, Keist R, Rudolph U, Zeilhofer HU (2011) Presynaptic alpha2-GABAA receptors in primary afferent depolarization and spinal pain control. J Neurosci 31:8134–8142
40. Malcangio M, Bowery NG (1994) Spinal cord SP release and hyperalgesia in monoarthritic rats: involvement of the GABAB receptor system. Br J Pharmacol 113:1561–1566
41. Yang K, Ma WL, Feng YP, Dong YX, Li YQ (2002) Origins of GABA(B) receptor-like immunoreactive terminals in the rat spinal dorsal horn. Brain Res Bull 58:499–507
42. Mahmoudi M, Zarrindast MR (2002) Effect of intracerebroventricular injection of GABA receptor agents on morphine-induced antinociception in the formalin test. J Psychopharmacol 16:85–91
43. Reyes-Vazquez C, Enna SJ, Dafny N (1986) The parafasciculus thalami as a site for mediating the antinociceptive response to GABAergic drugs. Brain Res 383:177–184
44. Ulrich D, Bettler B (2007) GABA(B) receptors: synaptic functions and mechanisms of diversity. Curr Opin Neurobiol 17:298–303
45. Potes CS, Neto FL, Castro-Lopes JM (2006) Inhibition of pain behavior by GABA(B) receptors in the thalamic ventrobasal complex: effect on normal rats subjected to the formalin test of nociception. Brain Res 1115:37–47
46. Andreou AP, Shields KG, Goadsby PJ (2010) GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus. Neurobiol Dis 37:314–323
47. Kirouac GJ, Li S, Mabrouk G (2004) GABAergic projection from the ventral tegmental area and substantia nigra to the periaqueductal gray region and the dorsal raphe nucleus. J Comp Neurol 469:170–184
48. Gilbert AK, Franklin KB (2001) GABAergic modulation of descending inhibitory systems from the rostral ventromedial medulla (RVM). Dose-response analysis of nociception and neurological deficits. Pain 90:25–36
49. Jasmin L, Rabkin SD, Granato A, Boudah A, Ohara PT (2003) Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 424:316–320
50. Depaulis A, Morgan MM, Liebeskind JC (1987) GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat. Brain Res 436:223–228
51. Drower EJ, Hammond DL (1988) GABAergic modulation of nociceptive threshold: effects of THIP and bicuculline microinjected in the ventral medulla of the rat. Brain Res 450:316–324
52. Hama AT, Fritschy JM, Hammond DL (1997) Differential distribution of (GABA)A receptor subunits on bulbospinal serotonergic and nonserotonergic neurons of the ventromedial medulla of the rat. J Comp Neurol 384:337–348
53. Hough LB, Nalwalk JW, Leurs R, Menge WM, Timmerman H (2001) Significance of GABAergic systems in the action of improgan, a non-opioid analgesic. Life Sci 68:2751–2757
54. Hasanein P, Mirazi N, Javanmardi K (2008) GABAA receptors in the central nucleus of amygdala (CeA) affect on pain modulation. Brain Res 1241:36–41
55. Rudolph U, Mohler H (2004) Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44:475–498
56. Zheng W, Xie W, Zhang J, Strong JA, Wang L, Yu L, Xu M, Lu L (2003) Function of gamma-aminobutyric acid receptor/channel rho 1 subunits in spinal cord. J Biol Chem 278:48321–48329
57. Knabl J, Witschi R, Hosl K, Reinold H, Zeilhofer UB, Ahmadi S, Brockhaus J, Sergejeva M, Hess A, Brune K, Fritschy JM, Rudolph U, Mohler H, Zeilhofer HU (2008) Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 451:330–334
58. Krogsgaard-Larsen P, Frolund B, Liljefors T, Ebert B (2004) GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Biochem Pharmacol 68:1573–1580
59. Ugarte SD, Homanics GE, Firestone LL, Hammond DL (2000) Sensory thresholds and the antinociceptive effects of GABA receptor agonists in mice lacking the beta3 subunit of the GABA(A) receptor. Neuroscience 95:795–806
60. Bonin RP, Labrakakis C, Eng DG, Whissell PD, De Koninck Y, Orser BA (2011) Pharmacological enhancement of delta-subunit-containing GABA(A) receptors that generate a tonic inhibitory conductance in spinal neurons attenuates acute nociception in mice. Pain 152:1317–1326
61. Magnaghi V, Ballabio M, Camozzi F, Colleoni M, Consoli A, Gassmann M, Lauria G, Motta M, Procacci P, Trovato AE, Bettler B (2008) Altered peripheral myelination in mice lacking GABAB receptors. Mol Cell Neurosci 37:599–609
62. Schuler V, Luscher C, Blanchet C, Klix N, Sansig G, Klebs K, Schmutz M, Heid J, Gentry C, Urban L, Fox A, Spooren W, Jaton AL, Vigouret J, Pozza M, Kelly PH, Mosbacher J, Froestl W, Kaslin E, Korn R, Bischoff S, Kaupmann K, van der Putten H, Bettler B (2001) Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 31:47–58
63. Gangadharan V, Agarwal N, Brugger S, Tegeder I, Bettler B, Kuner R, Kurejova M (2009) Conditional gene deletion reveals functional redundancy of GABAB receptors in peripheral nociceptors in vivo. Mol Pain 5:68
64. Drew GM, Siddall PJ, Duggan AW (2004) Mechanical allodynia following contusion injury of the rat spinal cord is associated with loss of GABAergic inhibition in the dorsal horn. Pain 109:379–388
65. Gwak YS, Tan HY, Nam TS, Paik KS, Hulsebosch CE, Leem JW (2006) Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. J Neurotrauma 23:1111–1124
66. Ibuki T, Hama AT, Wang XT, Pappas GD, Sagen J (1997) Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience 76:845–858
67. Meisner JG, Marsh AD, Marsh DR (2010) Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. J Neurotrauma 27:729–737
68. Miletic G, Draganic P, Pankratz MT, Miletic V (2003) Muscimol prevents long-lasting potentiation of dorsal horn field potentials in rats with chronic constriction injury exhibiting decreased levels of the GABA transporter GAT-1. Pain 105:347–353
69. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ (2002) Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22:6724–6731
70. Somers DL, Clemente FR (2002) Dorsal horn synaptosomal content of aspartate, glutamate, glycine and GABA are differentially altered following chronic constriction injury to the rat sciatic nerve. Neurosci Lett 323:171–174
71. Zhang AL, Hao JX, Seiger A, Xu XJ, Wiesenfeld-Hallin Z, Grant G, Aldskogius H (1994) Decreased GABA immunoreactivity in spinal cord dorsal horn neurons after transient spinal cord ischemia in the rat. Brain Res 656:187–190
72. Polgar E, Hughes DI, Riddell JS, Maxwell DJ, Puskar Z, Todd AJ (2003) Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain. Pain 104:229–239
73. Lu Y, Zheng J, Xiong L, Zimmermann M, Yang J (2008) Spinal cord injury-induced attenuation of GABAergic inhibition in spinal dorsal horn circuits is associated with down-regulation of the chloride transporter KCC2 in rat. J Physiol 586:5701–5715
74. Hwang JH, Yaksh TL (1997) The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain 70:15–22
75. Rode F, Jensen DG, Blackburn-Munro G, Bjerrum OJ (2005) Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain. Eur J Pharmacol 516:131–138
76. Eaton MJ, Martinez MA, Karmally S (1999) A single intrathecal injection of GABA permanently reverses neuropathic pain after nerve injury. Brain Res 835:334–339
77. Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De Koninck P, De Koninck Y (2003) Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424:938–942
78. von Heijne M, Hao JX, Sollevi A, Xu XJ (2001) Effects of intrathecal morphine, baclofen, clonidine and R-PIA on the acute allodynia-like behaviours after spinal cord ischaemia in rats. Eur J Pain 5:1–10
79. Asiedu MN, Mejia G, Ossipov MK, Malan TP, Kaila K, Price TJ (2012) Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice. J Pain 13:546–554
80. Zarrindast M, Valizadeh S, Sahebgharani M (2000) GABA(B) receptor mechanism and imipramine-induced antinociception in ligated and non-ligated mice. Eur J Pharmacol 407:65–72
81. Zarrindast MR, Mahmoudi M (2001) GABA mechanisms and antinociception in mice with ligated sciatic nerve. Pharmacol Toxicol 89:79–84
82. Deseure K, Koek W, Adriaensen H, Colpaert FC (2003) Continuous administration of the 5-hydroxytryptamine1A agonist (3-chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain. J Pharmacol Exp Ther 306:505–514
83. Franek M, Vaculin S, Rokyta R (2004) GABA(B) receptor agonist baclofen has non-specific antinociceptive effect in the model of peripheral neuropathy in the rat. Physiol Res 53:351–355
84. Nowak P, Kowalinska-Kania M, Nowak D, Kostrzewa RM, Malinowska-Borowska J (2013) Antinociceptive effects of H(3) (R-methylhistamine) and GABA(B) (baclofen)-receptor ligands in an orofacial model of pain in rats. Neurotox Res 24:258–264
85. Whitehead RA, Puil E, Ries CR, Schwarz SK, Wall RA, Cooke JE, Putrenko I, Sallam NA, MacLeod BA (2012) GABA(B) receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline. Neuroscience 213:154–160
86. Cui JG, Linderoth B, Meyerson BA (1996) Effects of spinal cord stimulation on touch-evoked allodynia involve GABAergic mechanisms. An experimental study in the mononeuropathic rat. Pain 66:287–295
87. Wang XL, Zhang HM, Chen SR, Pan HL (2007) Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy. J Physiol 579:849–861
88. Laffray S, Bouali-Benazzouz R, Papon MA, Favereaux A, Jiang Y, Holm T, Spriet C, Desbarats P, Fossat P, Le Feuvre Y, Decossas M, Heliot L, Langel U, Nagy F, Landry M (2012) Impairment of GABAB receptor dimer by endogenous 14-3-3zeta in chronic pain conditions. EMBO J 31:3239–3251
89. Hammond DL, Drower EJ (1984) Effects of intrathecally administered THIP, baclofen and muscimol on nociceptive threshold. Eur J Pharmacol 103:121–125
90. Hill RC, Maurer R, Buescher HH, Roemer D (1981) Analgesic properties of the GABA-mimetic THIP. Eur J Pharmacol 69:221–224
91. Green GM, Dickenson A (1997) GABA-receptor control of the amplitude and duration of the neuronal responses to formalin in the rat spinal cord. Eur J Pain 1:95–104
92. Kaneko M, Hammond DL (1997) Role of spinal gamma-aminobutyric acidA receptors in formalin-induced nociception in the rat. J Pharmacol Exp Ther 282:928–938
93. Dirig DM, Yaksh TL (1995) Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharmacol Exp Ther 275:219–227
94. Zambotti F, Zonta N, Tammiso R, Conci F, Hafner B, Zecca L, Ferrario P, Mantegazza P (1991) Effects of diazepam on nociception in rats. Naunyn-Schmiedeberg’s Arch Pharmacol 344:84–89
95. Zeilhofer HU, Mohler H, Di Lio A (2009) GABAergic analgesia: new insights from mutant mice and subtype-selective agonists. Trends Pharmacol Sci 30:397–402
96. Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131–134
97. Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Mohler H (1999) Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401:796–800
98. Rudolph U, Knoflach F (2011) Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 10:685–697
99. Guerrini G, Ciciani G, Bruni F, Selleri S, Martini C, Daniele S, Ghelardini C, Di Cesare Mannelli L, Costanzo A (2011) Development of ligands at gamma-aminobutyrric acid type A (GABAA) receptor subtype as new agents for pain relief. Bioorg Med Chem 19:7441–7452
100. Fritschy JM, Mohler H (1995) GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359:154–194
101. Reichl S, Augustin M, Zahn PK, Pogatzki-Zahn EM (2012) Peripheral and spinal GABAergic regulation of incisional pain in rats. Pain 153:129–141
102. Munro G, Lopez-Garcia JA, Rivera-Arconada I, Erichsen HK, Nielsen EO, Larsen JS, Ahring PK, Mirza NR (2008) Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3′-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 327:969–981
103. Mirza NR, Larsen JS, Mathiasen C, Jacobsen TA, Munro G, Erichsen HK, Nielsen AN, Troelsen KB, Nielsen EO, Ahring PK (2008) NS11394 [3′-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy. J Pharmacol Exp Ther 327:954–968
104. Hansen RR, Erichsen HK, Brown DT, Mirza NR, Munro G (2012) Positive allosteric modulation of GABA-A receptors reduces capsaicin-induced primary and secondary hypersensitivity in rats. Neuropharmacology 63:1360–1367
105. Munro G, Erichsen HK, Rae MG, Mirza NR (2011) A question of balance–positive versus negative allosteric modulation of GABA(A) receptor subtypes as a driver of analgesic efficacy in rat models of inflammatory and neuropathic pain. Neuropharmacology 61:121–132
106. Di Lio A, Benke D, Besson M, Desmeules J, Daali Y, Wang ZJ, Edwankar R, Cook JM, Zeilhofer HU (2011) HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain. Neuropharmacology 60:626–632
107. Nickolls S, Mace H, Fish R, Edye M, Gurrell R, Ivarsson M, Pitcher T, Tanimoto-Mori S, Richardson D, Sweatman C, Nicholson J, Ward C, Jinks J, Bell C, Young K, Rees H, Moss A, Kinloch R, McMurray G (2011) A comparison of the alpha2/3/5 selective positive allosteric modulators L-838,417 and TPA023 in preclinical models of inflammatory and neuropathic pain. Adv Pharmacol Sci 2011:608912
108. Carver CM, Reddy DS (2013) Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology 230:151–188
109. Yokoro CM, Pesquero SM, Turchetti-Maia RM, Francischi JN, Tatsuo MA (2001) Acute phenobarbital administration induces hyperalgesia: pharmacological evidence for the involvement of supraspinal GABA-A receptors. Braz J Med Biol Res 34:397–405
110. Loomis CW, Khandwala H, Osmond G, Hefferan MP (2001) Coadministration of intrathecal strychnine and bicuculline effects synergistic allodynia in the rat: an isobolographic analysis. J Pharmacol Exp Ther 296:756–761
111. Fromm GH (1994) Baclofen as an adjuvant analgesic. J Pain Symptom Manag 9:500–509
112. Loubser PG, Akman NM (1996) Effects of intrathecal baclofen on chronic spinal cord injury pain. J Pain Symptom Manag 12:241–247
113. Sindrup SH, Jensen TS (2002) Pharmacotherapy of trigeminal neuralgia. Clin J Pain 18:22–27
114. Slonimski M, Abram SE, Zuniga RE (2004) Intrathecal baclofen in pain management. Reg Anesth Pain Med 29:269–276
115. Cheng JK, Lee SZ, Yang JR, Wang CH, Liao YY, Chen CC, Chiou LC (2004) Does gabapentin act as an agonist at native GABA(B) receptors? J Biomed Sci 11:346–355
116. Lanneau C, Green A, Hirst WD, Wise A, Brown JT, Donnier E, Charles KJ, Wood M, Davies CH, Pangalos MN (2001) Gabapentin is not a GABAB receptor agonist. Neuropharmacology 41:965–975
117. Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J, Belley M, Trimble L, Bateman K, Alder L, Smith A, McKernan R, Metters K, O’Neill GP, Lacaille JC, Hebert TE (2001) Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol 59:144–152
118. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN (1996) The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271:5768–5776
119. Li DP, Chen SR, Pan YZ, Levey AI, Pan HL (2002) Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol 543:807–818
120. Riley RC, Trafton JA, Chi SI, Basbaum AI (2001) Presynaptic regulation of spinal cord tachykinin signaling via GABA(B) but not GABA(A) receptor activation. Neuroscience 103:725–737
121. Reis GM, Duarte ID (2006) Baclofen, an agonist at peripheral GABAB receptors, induces antinociception via activation of TEA-sensitive potassium channels. Br J Pharmacol 149:733–739
122. Patel S, Naeem S, Kesingland A, Froestl W, Capogna M, Urban L, Fox A (2001) The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90:217–226
123. Brusberg M, Ravnefjord A, Martinsson R, Larsson H, Martinez V, Lindstrom E (2009) The GABA(B) receptor agonist, baclofen, and the positive allosteric modulator, CGP7930, inhibit visceral pain-related responses to colorectal distension in rats. Neuropharmacology 56:362–367
124. Carai MA, Colombo G, Froestl W, Gessa GL (2004) In vivo effectiveness of CGP7930, a positive allosteric modulator of the GABAB receptor. Eur J Pharmacol 504:213–216
125. Castelli MP, Casu A, Casti P, Lobina C, Carai MA, Colombo G, Solinas M, Giunta D, Mugnaini C, Pasquini S, Tafi A, Brogi S, Gessa GL, Corelli F (2012) Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABAB receptor. J Pharmacol Exp Ther 340:529–538
126. Frankowska M, Filip M, Przegalinski E (2007) Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol Rep 59:645–655
127. Gjoni T, Urwyler S (2008) Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization. Neuropharmacology 55:1293–1299
128. Hensler JG, Advani T, Burke TF, Cheng K, Rice KC, Koek W (2012) GABAB receptor-positive modulators: brain region-dependent effects. J Pharmacol Exp Ther 340:19–26
129. Slattery DA, Markou A, Froestl W, Cryan JF (2005) The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology 30:2065–2072
130. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, Kaupmann K (2003) N, N′-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J Pharmacol Exp Ther 307:322–330
131. Carai MA, Vacca G, Serra S, Colombo G, Froestl W, Gessa GL (2004) Suppression of GABA(B) receptor function in vivo by disulfide reducing agent, DL-dithiothreitol (DTT). Psychopharmacology 174:283–290
132. Borden LA, Murali Dhar TG, Smith KE, Weinshank RL, Branchek TA, Gluchowski C (1994) Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 269:219–224
133. Krogsgaard-Larsen P, Frolund B, Frydenvang K (2000) GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects. Curr Pharm Des 6:1193–1209
134. Soudijn W, van Wijngaarden I (2000) The GABA transporter and its inhibitors. Curr Med Chem 7:1063–1079
135. Laughlin TM, Tram KV, Wilcox GL, Birnbaum AK (2002) Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception. J Pharmacol Exp Ther 302:1168–1175
136. Zorn SH, Enna SJ (1985) GABA uptake inhibitors produce a greater antinociceptive response in the mouse tail-immersion assay than other types of GABAergic drugs. Life Sci 37:1901–1912
137. Alves ND, de Castro-Costa CM, de Carvalho AM, Santos FJ, Silveira DG (1999) Possible analgesic effect of vigabatrin in animal experimental chronic neuropathic pain. Arq Neuropsiquiatr 57:916–920
138. Zhu SS, Zeng YM, Wang JK, Yan R, Nie X, Cao JL (2005) Inhibition of thermal hyperalgesia and tactile allodynia by intrathecal administration of gamma-aminobutyric acid transporter-1 inhibitor NO-711 in rats with chronic constriction injury. Acta Physiol Sin 57:233–239
139. Novak V, Kanard R, Kissel JT, Mendell JR (2001) Treatment of painful sensory neuropathy with tiagabine: a pilot study. Clin Auton Res 11:357–361
140. Todorov AA, Kolchev CB, Todorov AB (2005) Tiagabine and gabapentin for the management of chronic pain. Clin J Pain 21:358–361
141. Zhang Z, Cai YQ, Zou F, Bie B, Pan ZZ (2011) Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 17:1448–1455
142. Zhou HY, Zhang HM, Chen SR, Pan HL (2007) Increased nociceptive input rapidly modulates spinal GABAergic transmission through endogenously released glutamate. J Neurophysiol 97:871–882
143. Anseloni VC, Gold MS (2008) Inflammation-induced shift in the valence of spinal GABA-A receptor-mediated modulation of nociception in the adult rat. J Pain 9:732–738
144. Quintero L, Cardenas R, Suarez-Roca H (2011) Stress-induced hyperalgesia is associated with a reduced and delayed GABA inhibitory control that enhances post-synaptic NMDA receptor activation in the spinal cord. Pain 152:1909–1922
145. Zhu Y, Dua S, Gold MS (2012) Inflammation-induced shift in spinal GABA(A) signaling is associated with a tyrosine kinase-dependent increase in GABA(A) current density in nociceptive afferents. J Neurophysiol 108:2581–2593
146. Pinto M, Lima D, Castro-Lopes J, Tavares I (2003) Noxious-evoked c-fos expression in brainstem neurons immunoreactive for GABAB, mu-opioid and NK-1 receptors. Eur J Neurosci 17:1393–1402
147. McCarson KE, Enna SJ (1999) Nociceptive regulation of GABA(B) receptor gene expression in rat spinal cord. Neuropharmacology 38:1767–1773
148. Sands SA, McCarson KE, Enna SJ (2003) Differential regulation of GABA B receptor subunit expression and function. J Pharmacol Exp Ther 305:191–196
149. McCarson KE, Enna SJ (1996) Relationship between GABAB receptor activation and neurokinin receptor expression in spinal cord. Pharmacol Res Commun 8:191–194
150. McCarson KE, Ralya A, Reisman SA, Enna SJ (2005) Amitriptyline prevents thermal hyperalgesia and modifications in rat spinal cord GABA(B) receptor expression and function in an animal model of neuropathic pain. Biochem Pharmacol 71:196–202